Cellectis (CLLS) Tops Q1 EPS by 8c

Cellectis (NASDAQ: CLLS) reported Q1 EPS of ($0.18), $0.08 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.02 million versus the consensus estimate of $13.02 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Grok Bot launches in early beta for select subscribers
• Citi raises Huya price target to $4.60 from $4.40